Selected article for: "chronic myelogenous leukemia and myelogenous leukemia"

Author: Kim, Jung-Eun; Song, Yoon-Jae
Title: Anti-varicella-zoster virus activity of cephalotaxine esters in vitro
  • Cord-id: aelmmw6r
  • Document date: 2018_11_19
  • ID: aelmmw6r
    Snippet: Harringtonine (HT) and homoharringtonine (HHT), alkaloid esters isolated from the genus Cephalotaxus, exhibit antitumor activity. A semisynthetic HHT has been approved for treatment of chronic myelogenous leukemia. In addition to antileukemic activity, HT and HHT are reported to possess potent antiviral activity. In this study, we investigated the effects of HT and HHT on replication of varicella-zoster virus (VZV) in vitro. HT and HHT, but not their biologically inactive parental alkaloid cepha
    Document: Harringtonine (HT) and homoharringtonine (HHT), alkaloid esters isolated from the genus Cephalotaxus, exhibit antitumor activity. A semisynthetic HHT has been approved for treatment of chronic myelogenous leukemia. In addition to antileukemic activity, HT and HHT are reported to possess potent antiviral activity. In this study, we investigated the effects of HT and HHT on replication of varicella-zoster virus (VZV) in vitro. HT and HHT, but not their biologically inactive parental alkaloid cephalotaxine (CET), significantly inhibited replication of recombinant VZV-pOka luciferase. Furthermore, HT and HHT, but not CET, strongly induced down-regulation of VZV lytic genes and exerted potent antiviral effects against a VZV clinical isolate. The collective data support the utility of HT and HHT as effective antiviral candidates for treatment of VZV-associated diseases.

    Search related documents:
    Co phrase search for related documents
    • acceptor site and luciferase reporter: 1, 2, 3
    • luciferase activity and lytic gene: 1
    • luciferase activity and lytic gene expression: 1
    • luciferase reporter and luminescent cell: 1
    • luciferase reporter and lytic gene: 1
    • luciferase reporter and lytic gene expression: 1